Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Oct 27, 2015HiFiBiO’s next generation antibody discovery platform to be presented by Pfizer Inc. at PEGS Europe 2015Aug 13, 2015HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.Jun 12, 2015HiFiBiO to present platform at next-generation antibodies conferenceJun 12, 2015HiFiBiO partners with Johnson & Johnson Innovation< 1 … 15 16 17
